Latest Insider Transactions at Liberty Latin America Ltd. (LILA)
This section provides a real-time view of insider transactions for Liberty Latin America Ltd. (LILA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Liberty Latin America Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Liberty Latin America Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
15,292
+21.97%
|
-
|
|
Mar 15
2021
|
Eric Louis Zinterhofer Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,554
+19.29%
|
-
|
|
Mar 15
2021
|
Eric Louis Zinterhofer Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,277
+23.66%
|
-
|
|
Mar 15
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
5,986
-21.47%
|
$83,804
$14.36 P/Share
|
|
Mar 15
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,698
-8.82%
|
$37,772
$14.5 P/Share
|
|
Mar 15
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,452
+23.61%
|
-
|
|
Mar 15
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,614
-13.76%
|
$22,596
$14.45 P/Share
|
|
Mar 15
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,725
+28.72%
|
-
|
|
Mar 01
2021
|
Betzalel Kenigsztein SVP, CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,252
+2.72%
|
-
|
|
Mar 01
2021
|
Betzalel Kenigsztein SVP, CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,126
+4.14%
|
-
|
|
Mar 01
2021
|
Vivek Khemka SVP, CT&PO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,608
-1.88%
|
$19,296
$12.47 P/Share
|
|
Mar 01
2021
|
Vivek Khemka SVP, CT&PO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,634
+6.17%
|
-
|
|
Mar 01
2021
|
Vivek Khemka SVP, CT&PO |
SELL
Payment of exercise price or tax liability
|
Direct |
964
-3.24%
|
$11,568
$12.44 P/Share
|
|
Mar 01
2021
|
Vivek Khemka SVP, CT&PO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,817
+8.65%
|
-
|
|
Mar 01
2021
|
Balan Nair President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,560
-0.76%
|
$54,720
$12.47 P/Share
|
|
Mar 01
2021
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,776
+2.56%
|
-
|
|
Mar 01
2021
|
Balan Nair President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,280
-0.79%
|
$27,360
$12.44 P/Share
|
|
Mar 01
2021
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,888
+2.66%
|
-
|
|
Mar 01
2021
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,135
-1.22%
|
$25,620
$12.47 P/Share
|
|
Mar 01
2021
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,512
+4.13%
|
-
|
|
Mar 01
2021
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,249
-1.28%
|
$14,988
$12.44 P/Share
|
|
Mar 01
2021
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,756
+3.7%
|
-
|
|
Mar 01
2021
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
2,187
-1.93%
|
$26,244
$12.47 P/Share
|
|
Mar 01
2021
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
7,512
+6.22%
|
-
|
|
Mar 01
2021
|
John M Winter SVP, CLO AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,285
-3.19%
|
$15,420
$12.44 P/Share
|
|
Mar 01
2021
|
John M Winter SVP, CLO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,756
+8.52%
|
-
|
|
Mar 01
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
199
-0.93%
|
$2,388
$12.47 P/Share
|
|
Mar 01
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
580
+2.65%
|
-
|
|
Mar 01
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
100
-1.41%
|
$1,200
$12.44 P/Share
|
|
Mar 01
2021
|
Brian D Zook MD, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
290
+3.92%
|
-
|
|
Dec 31
2020
|
Alfonso De Angoitia Director |
BUY
Grant, award, or other acquisition
|
Direct |
650
+2.39%
|
$7,150
$11.09 P/Share
|
|
Dec 31
2020
|
Alfonso De Angoitia Director |
BUY
Grant, award, or other acquisition
|
Direct |
325
+3.29%
|
$3,575
$11.13 P/Share
|
|
Dec 31
2020
|
Paul A Gould Director |
BUY
Grant, award, or other acquisition
|
Direct |
950
+0.33%
|
$10,450
$11.09 P/Share
|
|
Dec 31
2020
|
Paul A Gould Director |
BUY
Grant, award, or other acquisition
|
Direct |
475
+0.43%
|
$5,225
$11.13 P/Share
|
|
Dec 31
2020
|
Brendan J Paddick Director |
BUY
Grant, award, or other acquisition
|
Direct |
650
+0.04%
|
$7,150
$11.09 P/Share
|
|
Dec 31
2020
|
Brendan J Paddick Director |
BUY
Grant, award, or other acquisition
|
Direct |
325
+0.05%
|
$3,575
$11.13 P/Share
|
|
Dec 31
2020
|
Eric Louis Zinterhofer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
650
+2.33%
|
$7,150
$11.09 P/Share
|
|
Dec 31
2020
|
Eric Louis Zinterhofer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
325
+3.3%
|
$3,575
$11.13 P/Share
|
|
Nov 20
2020
|
John C Malone > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
89,677
-2.08%
|
$986,447
$11.74 P/Share
|
|
Nov 19
2020
|
John C Malone > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
51,079
-1.17%
|
$561,869
$11.83 P/Share
|
|
Nov 18
2020
|
John C Malone > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
84,244
-1.89%
|
$1,010,928
$12.18 P/Share
|
|
Oct 08
2020
|
Eric Louis Zinterhofer Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
255,397
+2.33%
|
$1,787,779
$7.14 P/Share
|
|
Oct 07
2020
|
Michael T Fries Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,008
+0.7%
|
$21,056
$7.14 P/Share
|
|
Oct 07
2020
|
Vivek Khemka SVP, CT&PO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,305
+1.6%
|
$9,135
$7.14 P/Share
|
|
Oct 07
2020
|
Balan Nair President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,956
+1.68%
|
$69,692
$7.14 P/Share
|
|
Oct 07
2020
|
Christopher J Noyes SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,274
+0.76%
|
$8,918
$7.14 P/Share
|
|
Oct 07
2020
|
Daniel E. Sanchez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+2.48%
|
$476
$7.14 P/Share
|
|
Oct 05
2020
|
Charles H R Bracken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,799
+15.37%
|
-
|
|
Oct 05
2020
|
Miranda Curtis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
765
+4.77%
|
-
|
|
Oct 05
2020
|
Alfonso De Angoitia Director |
BUY
Exercise of conversion of derivative security
|
Direct |
372
+1.41%
|
-
|